↓ Skip to main content

Does cancer deserve special treatment when health technologies are prioritized?

Overview of attention for article published in Israel Journal of Health Policy Research, November 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users
googleplus
1 Google+ user

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Does cancer deserve special treatment when health technologies are prioritized?
Published in
Israel Journal of Health Policy Research, November 2013
DOI 10.1186/2045-4015-2-45
Pubmed ID
Authors

Paul Hansen

Abstract

Despite most new cancer treatments having relatively high costs and low health benefits, they are often funded ahead of treatments for other illnesses. And yet, according to the article by Dan Greenberg and colleagues, most Israeli oncologists and family physicians think that new cancer treatments should not receive such a high priority and that cost-effectiveness data should be used to support funding decisions. In this commentary, I point out that the increasing pressure worldwide when prioritizing health technologies to widen the scope of the benefits that are recognized beyond just narrowly-defined health benefits would almost certainly include the special characteristics of cancer. Future research would be worthwhile into how the criteria for prioritizing technologies should be incorporated into prioritization frameworks in practice, including, in particular, how to resolve the inherent trade-offs.This is a commentary on http://www.ijhpr.org/content/2/2/44/

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 10%
Unknown 9 90%

Demographic breakdown

Readers by professional status Count As %
Other 2 20%
Professor > Associate Professor 1 10%
Unspecified 1 10%
Student > Doctoral Student 1 10%
Student > Master 1 10%
Other 0 0%
Unknown 4 40%
Readers by discipline Count As %
Medicine and Dentistry 3 30%
Unspecified 1 10%
Economics, Econometrics and Finance 1 10%
Nursing and Health Professions 1 10%
Unknown 4 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 February 2014.
All research outputs
#12,888,337
of 22,733,113 outputs
Outputs from Israel Journal of Health Policy Research
#187
of 577 outputs
Outputs of similar age
#156,804
of 302,174 outputs
Outputs of similar age from Israel Journal of Health Policy Research
#5
of 10 outputs
Altmetric has tracked 22,733,113 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 577 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 302,174 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.